Forte Biosciences Stock (NASDAQ: FBRX) stock price, news, charts, stock research, profile.
Open | $0.51 |
Close | $0.51 |
Volume / Avg. | 2.08K / 22.53K |
Day Range | 0.50 - 0.51 |
52 Wk Range | 0.38 - 1.04 |
Market Cap | $19.10M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.05% |
Days to Cover | 1.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Forte Biosciences (NASDAQ:FBRX) through any online brokerage.
Other companies in Forte Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Lumos Pharma (NASDAQ:LUMO), Nanoviricides (AMEX:NNVC), Sensei Biotherapeutics (NASDAQ:SNSE) and GlycoMimetics (NASDAQ:GLYC).
There is no analysis for Forte Biosciences.
Forte Biosciences has a consensus price target of $2.65.
The stock price for Forte Biosciences (NASDAQ: FBRX) is $0.5242 last updated July 2, 2024 at 4:45 PM EDT.
There are no upcoming dividends for Forte Biosciences.
Forte Biosciences’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Forte Biosciences.
Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.